Healthcare
Sequoia leads Series B round in China menstruation-tracking app
Sequoia Capital China has led a Series B round of founding for Dayima.com, a menstruation cycle-tracking mobile app. Existing backer Bertelsmann Asia Investments also participated in the round.
Affordable healthcare chain Glocal gets $4m from SIDBI VC
SIDBI Venture Capital has invested INR250 million ($3.93 million) in Glocal Healthcare Systems, which operates multi-specialty hospitals in semi-rural parts of East India.
TPG invests $23m in Sutures India
TPG Growth has acquired a minority stake in Bangalore-based surgical equipment maker Sutures India for INR1.45 billion ($22.9 million).
Shanghai Sinopharm PE invests in chemical firm Anhui Fulltime
Sinopharm Capital, a private equity arm of Chinese drug distributing conglomerate Sinopharm, has made a pre-IPO investment in chemical products manufacturer Anhui Fulltime Specialized Solvent & Reagent.
Orion Partners to launch $250m Japan care homes fund
Hong Kong-headquartered Orion Partners, formerly known as Ajia Partners, is looking to raise as much as JPY25 billion ($250 million) for its third Japan care homes investment fund.
Morgan Stanley PE Asia makes partial exit from Sihuan Pharma
Morgan Stanley Private Equity Asia (MSPEA) will make a partial exit from Hong Kong-listed Sihuan Pharmaceutical Holdings, joining company management in selling a 6.8% stake via a block trade agreement.
Standard Chartered PE raises stake in Fortis Healthcare
Standard Chartered Private Equity (SCPE) has invested a further INR370.3 million ($5.7 million) to buy preferential shares in India’s Fortis Healthcare. It brings SCPE’s total investment into the company to approximately INR2.5 billion.
Matrix India commits $6m to Meditrina Hospitals
Matrix Partners India has invested INR400 million ($6 million) in Kerala-based Meditrina Hospitals for a significant minority stake. The private equity firm is the sole participant in the first round of investment.
Quadria reaches first close on South, Southeast Asia healthcare fund
Quadria Capital has reached a first close of $107 million on its second fund, which invests in mid-size healthcare companies in South and Southeast Asia. This is the first vehicle the GP has raised independently, its predecessor being the Milestone Religare...
China's BVCF targets super bacteria
“Large pharmaceutical firms aren’t putting a lot of resources into developing antibiotics nowadays because they can make more money producing drugs for chronic-related diseases, or cancer treatments,” observes Zhi Yang, founder and managing partner of...
Mandarin Capital exits IMA Group, has first close on Fund II
Mandarin Capital, a Chinese-Italian private equity fund, has sold its 7.57% stake in Bologna-based pharmaceutical machinery business IMA Group for EUR53 million ($69.7 million) and has made first close of its second fund on EUR110.5 million.
Carlyle, Cathay Capital, PingAn jointly invest in Meinian Onehealth
A consortium, comprising The Carlyle Group, Cathay Capital Private Equity and China Ping An Insurance, has agreed to invest RMB300 million ($49 million) in Meinian Onehealth Healthcare Group, the largest private provider of preventive healthcare check-up...
Simcere accepts Hony-backed take-private bid worth $490m
Chinese drug developer Simcere Pharmaceutical Group has agreed to a management buyout offer from a consortium led by its chairman and Hony Capital that values the company at approximately $490 million. Simcere is now expected to de-list from the New York...
Baird Capital invests in China's Kedu Healthcare
Baird Capital, the private investment arm of Robert W. Baird & Co, has invested in Kedu Healthcare, one of China's largest independent medical equipment service providers.
Australia announces new $225m biotech venture capital fund
The Australian government will contribute A$125 million ($112.6 million) to the A$250 million Medical Research Innovation Fund (MRIF), with the private sector to make up the other half.
INCJ leads $11m investment in Japan blood biotech venture
The Innovation Network Corporation of Japan (INCJ) has led a JPY1.16 billion ($11.7 million) investment in Megakaryon Corp, which is developing technology to produce blood platelets using reprogrammed stem cells.
KKR, Bain to enter final bidding for Panasonic healthcare unit - report
KKR, Toshiba Corp. and a consortium including Bain Capital, Mitsui & Co. and Development Bank of Japan are expected to participate in the final round of bidding for Panasonic’s healthcare unit.
China-focused BVCF leads $25m round for MicuRx Pharma
BVCF, a China-focused private equity growth fund specializing in life sciences, has a led a $25 million Series B round for MicuRX Paharmaceuticals, a biopaharma firm developing next generation antibiotics. The round also includes existing backers Morningside...
PE firms bid for Fortis' Quality Healthcare - report
The Carlyle Group, Advent International and Mitsui and Co. are among the 10 bidders for Hong Kong’s Quality Healthcare Medical Services, which is being sold by PE-backed Fortis Healthcare.
OrbiMed targets $300m for second Asia healthcare fund
Healthcare-focused private equity firm OrbiMed Advisors is targeting $300 million for its second Asia fund. The PE firm raised $188 million for its debut regional vehicle in 2008.
Abraaj, CDC back India's Rainbow Hospitals
The Abraaj Group and CDC, the UK government’s development finance arm, have together committed $17.5 million to Rainbow Hospitals, a pediatric and maternity healthcare facility in the southern Indian state of Andhra Pradesh. The size of the stake was...
ASK Pravi invests $9.7m in India's OMNI Hospitals
ASK Pravi Capital Advisors has invested INR600 million ($9.7 million) in the tertiary care OMNI Hospitals chain for a significant minority stake.
Actis makes another attempt to sell India's Sterling Hospitals – report
Olympus Capital-backed DM healthcare and Temasek’s HealthCare Global (HCG) are reported to be making offers for Actis Capital's Sterling Hospitals.
Malaysia's Khazanah in Turkish insurance buyout, Abraaj exits
Malaysian sovereign wealth fund Khazanah Nasional has agreed to pay $252 million for a 90% stake in Turkish health insurer Acibadem Sigorta. The investment facilitates the exit of The Abraaj Group, which held a 50% stake in the business.